Mark Levine
National Institutes of Health
4 papers in the Anchorcite directory, published between 2003 and 2008, cited 4,972 times in total.
ORCID profileResearch topics
- Vitamin C and Antioxidants Research · 4 papers
- Antioxidant Activity and Oxidative Stress · 2 papers
- Cancer and biochemical research · 2 papers
- Phytochemicals and Antioxidant Activities · 1 paper
- Redox biology and oxidative stress · 1 paper
- Complementary and Alternative Medicine Studies · 1 paper
Frequent co-authors
- Sebastian J. Padayatty · 2 papers
- Arie Katz · 2 papers
- Yaohui Wang · 2 papers
- Christopher Peter Corpe · 2 papers
- Michael Graham Espey · 2 papers
- Murali Cherukuri Krishna · 2 papers
- Peter Eck · 1 paper
- Oran Kwon · 1 paper
Papers
- Vitamin C as an Antioxidant: Evaluation of Its Role in Disease PreventionJournal of the American College of Nutrition · 2003 · 2,012 citations
Vitamin C in humans must be ingested for survival. Vitamin C is an electron donor, and this property accounts for all its known functions. As an electron donor, vitamin C is a potent water-soluble antioxidant in humans. Antioxidant effects of…
- Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissuesProceedings of the National Academy of Sciences · 2005 · 1,083 citations
Human pharmacokinetics data indicate that i.v. ascorbic acid (ascorbate) in pharmacologic concentrations could have an unanticipated role in cancer treatment. Our goals here were to test whether ascorbate killed cancer cells selectively, and if so, to determine mechanisms, using clinically…
- Vitamin C Pharmacokinetics: Implications for Oral and Intravenous UseAnnals of Internal Medicine · 2004 · 1,015 citations
BACKGROUND: Vitamin C at high concentrations is toxic to cancer cells in vitro. Early clinical studies of vitamin C in patients with terminal cancer suggested clinical benefit, but 2 double-blind, placebo-controlled trials showed none. However, these studies used different routes…
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences · 2008 · 862 citations
Ascorbic acid is an essential nutrient commonly regarded as an antioxidant. In this study, we showed that ascorbate at pharmacologic concentrations was a prooxidant, generating hydrogen-peroxide-dependent cytotoxicity toward a variety of cancer cells in vitro without adversely affecting normal cells.…
Metadata from OpenAlex (CC0).